Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prucalopride effects on reflux and upper gastrointestinal motility in healthy volunteers
NL-OMON35936Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prucalopride in gastroesophageal reflux disease (GERD) and functional dyspepsia (FD), sponsored by Amsterdam University Medical Center. Primary endpoint: Number of esophageal reflux episodes during the 24-hour study. Started Jul 2012; status: active, not recruiting.
02
Drugs
prucalopride
03
Conditions
gastroesophageal reflux disease (GERD)functional dyspepsia (FD)
Beyond the preview
Go deeper on NL-OMON35936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35936.